Carl Gustav Figdor#
| Membership Number: | 3428 |
| Membership type: | ORDINARY |
| Section: | PHYSIOLOGY & NEUROSCIENCE |
| Elected: | 2012 |
| Main Country of Residence: | THE NETHERLANDS |
| Homepage(s): | http://www.ncmls.eu |
Present and Previous Positions
- 2001 - 2010 Scientific director of the Nijmegen Centre for Molecular Life Sciences (NCMLS), Radboud University Nijmegen Medical Centre
- 1994 - present Full professor in Immunology and Head of the Department of Tumor Immunology at the Radboud University Nijmegen Medical Centre
- 1992 - 2009 Full professor in Cell Biophysics at the Twente University
- 1988 - 1994 Associate professor at the Netherlands Cancer Institute, Department of Immunology
- 1982 - 1988 Assistant professor at the Netherlands Cancer Institute, Department of Immunology
- 1979 - 1982 PhD student at the Netherlands Cancer Institute, Division of Immunology
Fields of Scholarship
- Molecular cell biology and biophysics
- Molecular immunology
- Translational research, dendritic cell vaccination in cancer patients
- Tumor microenvironment
- Understanding the relation between tumor, stroma and infiltrating immune cells
Honours and Awards
- 1999 Van Loghem Award, Dutch Society of Immunology
- 2000 Eijkman Medal, Utrecht. This is an oeuvre award in the field of immunology, awarded for significant contributions to the field
- 2006 Spinoza Award, Netherlands Organisation for Scientific research (NWO). The Spinoza award is the highest scientific prize given to Dutch scientists by the Netherlands Organisation for Scientific Research (NWO). The prizes are awarded annual to distinguished scientists. More information can be found via NWO: (NWO Spinoza prizes), and (Jury report). The prize was awarded for ‘groundbreaking research into the use of immune cells against cancer and for how he translates fundamental research into patient care’. The Spinoza award is associated with 1.5 M€ for research
- 2008 Member of the Royal Netherlands Academy of Arts and Sciences
- 2009 Dutch Cancer Foundation research award (2 M€) for outstanding translational cancer research.
- 2010 ERC Advanced Grant (1.5 M€)
- 2012 Knight of the Order of the Dutch Lion
